|
"chou wc"的相關文件
顯示項目 1-25 / 121 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-07 |
5-FU+Nal-IRI vs FOLFOX/XELOX as second-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after gemcitabine and nab-paclitaxel (GemNab): A propensity score-matched analysis
|
Trovato, G;Rossini, D;Su, YY;Shan, YS;Chou, WC;Bagala, C;Bensi, M;Niger, M;Marchesi, S;Garattini, SK;Michelotti, A;Chiang, NJ;Pretta, A;Scartozzi, M;Vivaldi, C;Bartalini, L;Procaccio, L;Chen, LT;Tortora, G;Salvatore, L |
| 國家衛生研究院 |
2024-09-07 |
Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts
|
Hung, LJ;Huang, CY;Tung, KC;Chen, JS;Huang, WK;Hsu, CC;Fang, YF;Wang, CL;Liu, PC;Yeh, KY;Chang, PH;Chang, JWC;Lin, YC;Huang, SF;Chou, WC |
| 國家衛生研究院 |
2024-08-12 |
Real-world insights from comprehensive genomic profiling across multiple cancer types
|
Hung, LJ;Huang, CY;Chen, JS;Huang, WK;Hsu, CC;Fang, YF;Wang, CL;Liu, PC;Yeh, KY;Chang, PH;Chang, JWC;Lin, YC;Huang, SF;Chou, WC |
| 國家衛生研究院 |
2024-03-25 |
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer
|
Tang, CY;Yang, SH;Li, CP;Su, YY;Chiu, SC;Bai, LY;Shan, YS;Chen, LT;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chiang, NJ;Chou, WC |
| 國家衛生研究院 |
2023-12-31 |
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
|
Su, YY;Chiang, NJ;Chiu, TJ;Huang, CJ;Hsu, SJ;Lin, HC;Yang, SH;Yang, Y;Chou, WC;Chen, YY;Bai, LY;Li, CP;Chen, JS |
| 國家衛生研究院 |
2023-07 |
Human biomonitoring reference values, exposure distribution, and characteristics of metals in the general population of Taiwan: Taiwan environmental survey for Toxicants (TESTs), 2013–2016
|
Liao, KW;Chen, PC;Chou, WC;Shiue, I;Huang, HI;Chang, WT;Huang, PC |
| 國家衛生研究院 |
2023-06-12 |
Unveiling the hidden dangers of plasticizers: A call for immediate action
|
Huang, PC;Chou, WC |
| 國家衛生研究院 |
2023-02-05 |
Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer
|
Su, YY;Chiang, NJ;Yang, YH;Yen, CJ;Bai, LY;Chiu, CF;Chuang, SC;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chan, DC;Peng, CM;Chiu, SC;Li, CP;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-11-15 |
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma
|
Chiang, NJ;Shan, YS;Li, CP;Yang, SH;Su, YY;Chiu, SC;Bai, LY;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2022-10-15 |
Cumulative risk assessment and exposure characteristics of parabens in the general Taiwanese using multiple hazard indices approaches
|
Huang, PC;Chen, HC;Chou, WC;Lin, HW;Chang, WT;Chang, JW |
| 國家衛生研究院 |
2022-09-15 |
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chen, YY;Hsueh, SW;Yang, SH;Chiu, SC;Chiang, NJ;Chiu, TJ;Li, CP;Bai, LY;Chiu, CF;Chuang, SC;Shan, YS;Chan, DCA;Chen, LT;Yen, CJ;Peng, CM;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2022-07-01 |
Mediation effects of thyroid function in the associations between phthalate exposure and lipid metabolism in adults
|
Huang, HB;Cheng, PK;Siao, CY;Lo, YTC;Chou, WC;Huang, PC |
| 國家衛生研究院 |
2022-06-22 |
Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study
|
Su, YY;Chiang, NJ;Li, CP;Yen, CJ;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chuang, SC;Bai, LY;Chiu, CF;Peng, CM;Chan, DC;Chiu, SC;Yang, YH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-06 |
Bisphenol A-toxicity and risk assessment update with academic and regulatory perspectives and physiologically based pharmacokinetic modeling
|
Fan, AM;Chou, WC;Lin, P |
| 國家衛生研究院 |
2022-04-15 |
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan
|
Yang, SH;Chiang, NJ;Chiu, SC;Chou, WC;Bai, LY;Li, CP;Su, YY;Chiu, TJ;Chuang, SC;Peng, CM;Chan, DC;Chen, JS;Yen, CJ;Chen, YY;Chiu, CF;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2022-02-19 |
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chiu, TJ;Yang, SH;Chiu, SC;Hsueh, SW;Chiang, NJ;Li, CP;Bai, LY;Cheng, FM;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Su, YY;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2022 |
Distinct immunogenetic profiles of chronic lymphocytic leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study
|
Yao, CY;Agathangelidis, A;Chuang, SS;Tsou, HH;Feng, WL;Liu, TC;Chen, TY;Yu, YB;Yeh, SP;Yao, M;Wang, CC;Lin, J;Hwang, WL;Gau, JP;Chou, WC;Chao, TY;Lin, LI;Tien, HF;Ghia, P;Wu, SJ |
| 國家衛生研究院 |
2021-11-20 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2021-09 |
Cumulative risk assessment of phthalates exposure for recurrent pregnancy loss in reproductive-aged women population using multiple hazard indices approaches
|
Chang, WH;Chou, WC;Waits, A;Liao, KW;Kuo, PL;Huang, PC |
| 國家衛生研究院 |
2021-06 |
Human biomonitoring reference values and characteristics of Phthalate exposure in the general population of Taiwan: Taiwan Environmental Survey for Toxicants 2013-2016
|
Liao, KW;Chang, WH;Chou, WC;Huang, HB;Waits, A;Chen, PC;Huang, PC |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 中山醫學大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study
|
Chiu, TJ; Su, YY; Yang, SH; Li, CP; Bai, LY; Chiang, NJ; Chuang, SC; Shan, YS; Chan, DC; Chen, LT; Yen, CJ; Peng, CM; Chen, YY; Chen, JS; Chou, WC |
| 臺大學術典藏 |
2020-09-29T16:47:19Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, YW; Tsai, CH; Lin, CC; Tien, FM; Chen, YW; HSIN-YI LIN; Yao, M; Lin, YC; Lin, CT; Cheng, CL; Tang, JL; Chou, WC; Hou, HA; Tien, HF |
| 中山醫學大學 |
2020 |
Assessing dietary exposure risk to neonicotinoid residues among preschool children in regions of Taiwan
|
Ling, MP; Hsiao, HA; Chen, SC; Chen, WY; Chou, WC; Lin, YJ; You, SH; Yang, YF; Lin, HC; Chen, CY; Lu, TH; Liao, CM |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
顯示項目 1-25 / 121 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
